Skip to main content
Caplight Logo









Genuv Inc.

Genuv Inc.

Private
SeoulHealthcare & Life Scienceshttps://genuv.com/

Last Round

Grant

Feb 1, 2024

Total Funding Raised

$24.41M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Genuv Inc. is a biotechnology company that develops treatments for neurodegenerative diseases and immuno-oncology therapeutics using proprietary drug discovery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug discoverybiopharmaceuticalphenotypic screeningantibody discoveryneurodegenerative diseaseimmuno-oncologybiotechCNS drug discoverytransgenic mousemonoclonal antibodyimmunocytokinebiologicssmall moleculedrug licensingpreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genuv Inc. Comparables

Compare Genuv Inc. with similar companies based on industry and business-model similarity.

Genuv Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Harbour BioMed
75%
Alloy Therapeutics
74%
Biocytogen
70%

Genuv Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2024
AcceleratorDec 12, 2022
GrantDec 10, 2021
Early FundingDec 1, 2020

Key People

Founding team and executive leadership

Sungho Han

Founder and Chief Executive Officer

Founding Team

Genuv Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 118% MoM, reaching 5.4K.

  • May 19, 2026

    Monthly visitors increased 58% MoM.

Genuv Inc. Filings

Explore SEC and related filing metadata, where available.

Genuv Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genuv Inc.'s valuation, stock price, and market status.

Is Genuv Inc. a public or private company?

Genuv Inc. is a private company.

What is the current stock price of Genuv Inc.?

Genuv Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Genuv Inc. worth (valuation)?

Valuation information for Genuv Inc. is not publicly available.

Can I buy Genuv Inc. stock?

Genuv Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genuv Inc.'s last funding round?

Genuv Inc.'s most recent funding round was Grant on February 1, 2024.

Who are the main investors in Genuv Inc.?

Key investors in Genuv Inc. include Kite Entrepreneurship Foundation, Korea Drug Development Fund, Alzheimer's Drug Discovery Foundation.

Will Genuv Inc. IPO soon?

No public IPO plans have been announced for Genuv Inc..

How can I track Genuv Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genuv Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range12
Year Founded2016
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?